Earnings Outlook For Aurinia Pharmaceuticals



Aurinia Pharmaceuticals (NASDAQ:AUPH) is set to give its latest quarterly earnings report on Thursday, 2024-02-15. Here’s what investors need to know before the announcement.

Analysts estimate that Aurinia Pharmaceuticals will report an earnings per share (EPS) of $-0.16.

Aurinia Pharmaceuticals bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …

Full story available on Benzinga.com


Leave a Reply

Your email address will not be published. Required fields are marked *